| Primary |
| Obsessive-compulsive Disorder |
29.6% |
| Depression |
18.5% |
| Psychotic Disorder |
14.8% |
| Bipolar Disorder |
7.4% |
| General Anaesthesia |
7.4% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
7.4% |
| Prophylaxis Of Neural Tube Defect |
7.4% |
| Dementia |
3.7% |
| Sleep Disorder |
3.7% |
|
| Drug Interaction |
16.7% |
| Aptyalism |
8.3% |
| Drug Ineffective |
8.3% |
| Epistaxis |
8.3% |
| Haemoglobin Decreased |
8.3% |
| Ketoacidosis |
8.3% |
| Medication Error |
8.3% |
| Myoclonus |
8.3% |
| Neuroleptic Malignant Syndrome |
8.3% |
| Renal Failure Acute |
8.3% |
| Xanthogranuloma |
8.3% |
|
| Secondary |
| Cancer Pain |
19.5% |
| Depression |
18.1% |
| Anxiety |
7.8% |
| Constipation |
7.7% |
| Schizophrenia |
7.5% |
| Hypertension |
7.4% |
| Blood Cholesterol Increased |
7.2% |
| Type 2 Diabetes Mellitus |
6.8% |
| Alcoholism |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Product Used For Unknown Indication |
2.6% |
| Insomnia |
1.3% |
| Sleep Disorder Therapy |
1.3% |
| Asthma |
1.2% |
| Delirium |
1.1% |
| Epilepsy |
1.1% |
| Obsessive-compulsive Disorder |
1.1% |
| Drug Exposure During Pregnancy |
0.9% |
| Atrial Fibrillation |
0.8% |
| Bipolar Disorder |
0.8% |
|
| White Blood Cell Count Increased |
44.4% |
| Thyroid Neoplasm |
9.3% |
| Somnolence |
7.4% |
| Orthostatic Hypotension |
5.6% |
| Mechanical Ventilation |
3.7% |
| Suicidal Ideation |
2.8% |
| Suicide Attempt |
2.8% |
| Toxic Skin Eruption |
2.8% |
| Tremor |
2.8% |
| Altered State Of Consciousness |
1.9% |
| Incorrect Dose Administered |
1.9% |
| Mania |
1.9% |
| Mood Altered |
1.9% |
| Nausea |
1.9% |
| Pollakiuria |
1.9% |
| Systemic Lupus Erythematosus |
1.9% |
| Transaminases Increased |
1.9% |
| Vomiting |
1.9% |
| Agitation |
0.9% |
| Coma Scale Abnormal |
0.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.2% |
| Depression |
12.3% |
| Hiv Infection |
12.3% |
| Hypertension |
6.8% |
| Prophylaxis |
6.8% |
| Product Used For Unknown Indication |
6.4% |
| Cataplexy |
4.8% |
| Infection Prophylaxis |
4.5% |
| Bone Marrow Conditioning Regimen |
2.7% |
| Cardiovascular Disorder |
2.7% |
| Necrosis |
2.7% |
| Diabetes Mellitus |
2.5% |
| Hepatitis C |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Anxiety Disorder |
2.3% |
| Prophylaxis Against Graft Versus Host Disease |
2.3% |
| Bipolar Disorder |
2.0% |
| Pain |
2.0% |
| Epilepsy |
1.8% |
| Mental Disorder |
1.8% |
|
| Vomiting |
10.2% |
| Weight Increased |
8.5% |
| Pulmonary Congestion |
6.8% |
| Pyrexia |
6.8% |
| Vertigo Positional |
6.8% |
| Depression |
5.1% |
| Hospitalisation |
5.1% |
| Insomnia |
5.1% |
| Off Label Use |
5.1% |
| Pain |
5.1% |
| Somnolence |
5.1% |
| Back Disorder |
3.4% |
| Diarrhoea |
3.4% |
| Disorientation |
3.4% |
| Drug Ineffective |
3.4% |
| Dyspnoea |
3.4% |
| Haemoglobin Decreased |
3.4% |
| Hypertension |
3.4% |
| Lumbar Spinal Stenosis |
3.4% |
| Mania |
3.4% |
|
| Interacting |
| Ill-defined Disorder |
60.0% |
| Depression |
20.0% |
| Attention Deficit/hyperactivity Disorder |
6.7% |
| Hypervigilance |
6.7% |
| Sleep Disorder Therapy |
6.7% |
|
| Serotonin Syndrome |
100.0% |
|
